GUJRATHI SHEILA
Reporting owner on Forms 3, 4 and 5, CIK 1575202.
GUJRATHI SHEILA reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-27.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| BOLT · Bolt Biotherapeutics, Inc.CIK 1641281 | director, officer (Chief Strategy Officer) | 1 | 2026-10-27 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| BOLT · Bolt Biotherapeutics, Inc.Common Stock | 2026-10-23 | A granted | +72,766 | $0 | 72,766 | Form 4 |
| BOLT · Bolt Biotherapeutics, Inc.Common Stock | 2026-10-23 | A granted | +13,055 | $0 | 13,055 | Form 4 |
| BOLT · Bolt Biotherapeutics, Inc.Series D Preferred Stock, derivative | 2026-10-23 | J other | +2,763.833 | 2,763.833 | Form 4 | |
| BOLT · Bolt Biotherapeutics, Inc.Series D Preferred Stock, derivative | 2026-10-23 | J other | +495.874 | 495.874 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-434468 | Bolt Biotherapeutics, Inc. | 2026-10-27 | ||
| Form 3 0001193125-26-434466 | Bolt Biotherapeutics, Inc. | 2026-10-27 |